1. Association between corrected QT interval and long-term cardiovascular outcomes in elderly patients who had undergone endovascular therapy for lower extremity arterial disease
- Author
-
Yao-Ting Chang, I-Shiang Tzeng, Shih-Jung Jang, Kuan-Liang Liu, Chien-An Hsieh, Hsin-Hua Chou, Kuan-Hung Yeh, Hsuan-Li Huang, and TRENDPAD Study Group
- Subjects
corrected QT interval ,mortality ,old aged ,low-extremity artery disease ,endovascular therapy ,major adverse cardiovascular events ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
BackgroundPopulation-based studies have reported the association between prolonged corrected QT (QTc) intervals and an increased risk of adverse cardiovascular events. Data regarding the association between longer QTc intervals and incident cardiovascular outcomes in patients with lower extremity arterial disease (LEAD) are scarce.ObjectiveTo examine the impact of QTc interval on long-term cardiovascular outcomes in elderly patients with symptomatic LEAD.MethodsThis cohort study extracted data from the Tzu-chi Registry of ENDovascular Intervention for Peripheral Artery Disease (TRENDPAD) and enrolled 504 patients aged ≥ 70 treated with endovascular therapy for atherosclerotic LEAD from July 1, 2005, to December 31, 2019. The main outcomes of interest were all-cause mortality and major adverse cardiovascular events (MACE). Multivariate analysis was conducted using the Cox proportional hazard model to determine independent variables. We performed interaction analysis between corrected QT and other covariates and Kaplan-Meier analysis to compare the outcome of interest among the groups stratified by the tercile of QTc intervals.ResultsA total of 504 patients [235 men (46.6%); mean age, 79.9 ± 6.2 years; mean QTc interval, 459 ± 33 msec] entered the final data analysis. We categorized the baseline patient characteristics according to terciles of QTc intervals. During the median follow-up time of 3.15 (interquartile ranges, 1.65–5.42) years, we noted 264 deaths and 145 MACEs. The 5-year rates of freedom from all-cause mortality (71% vs. 57% vs. 31%, P
- Published
- 2023
- Full Text
- View/download PDF